1. Home
  2. COGT vs LOMA Comparison

COGT vs LOMA Comparison

Compare COGT & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • LOMA
  • Stock Information
  • Founded
  • COGT 2014
  • LOMA 1926
  • Country
  • COGT United States
  • LOMA Argentina
  • Employees
  • COGT N/A
  • LOMA N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • LOMA Building Materials
  • Sector
  • COGT Health Care
  • LOMA Industrials
  • Exchange
  • COGT Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • COGT 984.0M
  • LOMA 819.2M
  • IPO Year
  • COGT 2018
  • LOMA 2017
  • Fundamental
  • Price
  • COGT $8.90
  • LOMA $10.35
  • Analyst Decision
  • COGT Buy
  • LOMA Sell
  • Analyst Count
  • COGT 6
  • LOMA 2
  • Target Price
  • COGT $14.67
  • LOMA $6.55
  • AVG Volume (30 Days)
  • COGT 1.3M
  • LOMA 682.7K
  • Earning Date
  • COGT 11-12-2024
  • LOMA 11-06-2024
  • Dividend Yield
  • COGT N/A
  • LOMA 1.43%
  • EPS Growth
  • COGT N/A
  • LOMA 22.88
  • EPS
  • COGT N/A
  • LOMA 0.63
  • Revenue
  • COGT N/A
  • LOMA $265,542,078.00
  • Revenue This Year
  • COGT N/A
  • LOMA N/A
  • Revenue Next Year
  • COGT N/A
  • LOMA N/A
  • P/E Ratio
  • COGT N/A
  • LOMA $16.43
  • Revenue Growth
  • COGT N/A
  • LOMA N/A
  • 52 Week Low
  • COGT $3.67
  • LOMA $5.70
  • 52 Week High
  • COGT $12.61
  • LOMA $10.67
  • Technical
  • Relative Strength Index (RSI)
  • COGT 28.97
  • LOMA 75.80
  • Support Level
  • COGT $9.97
  • LOMA $10.06
  • Resistance Level
  • COGT $11.16
  • LOMA $10.65
  • Average True Range (ATR)
  • COGT 0.78
  • LOMA 0.36
  • MACD
  • COGT -0.25
  • LOMA 0.07
  • Stochastic Oscillator
  • COGT 2.02
  • LOMA 82.11

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue Derives from Cement, masonry cement, and lime segment.

Share on Social Networks: